Intech Investment Management LLC trimmed its position in Aflac Incorporated (NYSE:AFL - Free Report) by 39.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,664 shares of the financial services provider's stock after selling 47,207 shares during the period. Intech Investment Management LLC's holdings in Aflac were worth $8,012,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Y.D. More Investments Ltd purchased a new position in Aflac in the 2nd quarter valued at $25,000. Darwin Wealth Management LLC purchased a new position in Aflac in the 3rd quarter valued at $34,000. Covestor Ltd grew its position in Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock valued at $41,000 after buying an additional 107 shares during the last quarter. Kennebec Savings Bank acquired a new stake in Aflac in the third quarter valued at $45,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in Aflac in the third quarter valued at $51,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Aflac Trading Up 0.6 %
AFL traded up $0.66 during midday trading on Friday, hitting $112.39. The company's stock had a trading volume of 1,606,623 shares, compared to its average volume of 2,215,278. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.32. The firm has a market cap of $62.44 billion, a P/E ratio of 16.88, a PEG ratio of 2.14 and a beta of 0.96. The firm has a 50-day moving average price of $110.66 and a two-hundred day moving average price of $100.24. Aflac Incorporated has a 52-week low of $75.07 and a 52-week high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analysts' expectations of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The firm's revenue was down 40.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 EPS. On average, research analysts anticipate that Aflac Incorporated will post 7.22 earnings per share for the current year.
Aflac Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.78%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac's dividend payout ratio (DPR) is 30.12%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on AFL shares. Piper Sandler raised their target price on Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. Truist Financial raised their target price on Aflac from $100.00 to $105.00 and gave the company a "hold" rating in a report on Friday, November 1st. Bank of America raised their target price on Aflac from $115.00 to $124.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Morgan Stanley lifted their price target on Aflac from $91.00 to $98.00 and gave the stock an "equal weight" rating in a research note on Monday, August 19th. Finally, UBS Group lifted their price target on Aflac from $84.00 to $109.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 14th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Aflac currently has an average rating of "Hold" and an average price target of $97.93.
Read Our Latest Research Report on Aflac
About Aflac
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
